Genzyme has officially inaugurated a €150 million expansion at their biotechnology campus in Waterford. Richard Bruton, Minister for Jobs, Enterprise and Innovation, officially opened the new facility on Wednesday.
The biotechnology site employing 500 people – including 60 from Kilkenny – has seen capital investment of €500 million since Genzyme’s arrival in Ireland 10 years ago. The most recent investment has increased capacity at the company’s manufacturing operation, accompanied by additional development capability, laboratory facilities and administration offices.
Minister Bruton said biotechnology and pharmaceuticals had been major parts of the success of multinational investment in Ireland in recent years. “If we are to get out of the crisis we are in, we must continuously build on these strengths. We must continually encourage companies in these sectors to locate more important parts of their operations in Ireland.
“We must also build on their presence here to create an indigenous engine of growth. I am determined to make the changes necessary to do just that and create the jobs we so badly need,” Minister Bruton said.
Genzyme is one of the world’s leading biotechnology companies, dedicated to making a major positive impact on the lives of people with serious diseases.
Since its founding in 1981, the company has introduced breakthrough treatments that have provided new hope for patients. The company’s areas of focus are rare genetic diseases, multiple sclerosis, cardiovascular disease and endocrinology.